Literature DB >> 12777388

Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities.

Frantisek Hubalek1, Jan Pohl, Dale E Edmondson.   

Abstract

Monoamine oxidases (MAO) A and B are approximately 60-kDa outer mitochondrial membrane flavoenzymes catalyzing the degradation of neurotransmitters and xenobiotic arylalkyl amines. Despite 70% identity of their amino acid sequences, both enzymes exhibit strikingly different properties when exposed to thiol-modifying reagents. Human MAO A and MAO B each contain 9 cysteine residues (7 in conserved sequence locations). MAO A is inactivated by N-ethylmaleimide (NEM) much faster (tau(1/2) = approximately 3 min) than MAO B (tau(1/2) = approximately 8 h). These differences in thiol reactivities are also demonstrated by monitoring the NEM modification stoichiometries by electrospray mass spectrometry. Inactivation of either enzyme with acetylenic inhibitors results in alterations of their thiol reactivities. Cys5 and Cys266 were identified as the only residues modified by biotin-derivatized NEM in clorgyline-inactivated MAO A and pargyline-inactivated MAO B, respectively. The x-ray structure of MAO B (Binda, C., Newton-Vinson, P., Hubalek, F., Edmondson, D. E., and Mattevi, A. (2002) Nat. Struct. Biol. 9, 22-26) shows that Cys5 is located on the surface of the molecule opposite to the membrane-binding region. Cys266 in MAO A is predicted to be located in the same region of the molecule. These thiol residues are also modified by biotin-derivatized NEM in the mitochondrial membrane-bound MAO A and MAO B. This study shows that the MAO A structure is "more flexible" than that of MAO B and that clorgyline and pargyline inactivation of MAO A and B, respectively, increases the structural stability of both enzymes. No evidence is found for the presence of disulfide bonds in either enzyme, contrary to a previous suggestion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777388     DOI: 10.1074/jbc.M303712200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Activity-dependent Regulation of Histone Lysine Demethylase KDM1A by a Putative Thiol/Disulfide Switch.

Authors:  Emily L Ricq; Jacob M Hooker; Stephen J Haggarty
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

2.  Anethole dithiolethione lowers the homocysteine and raises the glutathione levels in solid tissues and plasma of rats: a novel non-vitamin homocysteine-lowering agent.

Authors:  Daniela Giustarini; Paolo Fanti; Anna Sparatore; Elena Matteucci; Ranieri Rossi
Journal:  Biochem Pharmacol       Date:  2014-03-14       Impact factor: 5.858

3.  The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes.

Authors:  B Drukarch; J Flier; C A M Jongenelen; G Andringa; A N M Schoffelmeer
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

4.  Species differences in the selective inhibition of monoamine oxidase (1-methyl-2-phenylethyl)hydrazine and its potentiation by cyanide.

Authors:  Zakia Ben Ramadan; Maria L Wrang; Keith F Tipton
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

5.  Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B.

Authors:  Luigi De Colibus; Min Li; Claudia Binda; Ariel Lustig; Dale E Edmondson; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

6.  Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase.

Authors:  Chelsea T Tiernan; Ethan A Edwin; Hae-Young Hawong; Mónica Ríos-Cabanillas; John L Goudreau; William D Atchison; Keith J Lookingland
Journal:  Toxicol Sci       Date:  2015-01-19       Impact factor: 4.849

Review 7.  Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.

Authors:  Narayan D Chaurasiya; Francisco Leon; Ilias Muhammad; Babu L Tekwani
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

8.  Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.

Authors:  Pablo Duarte; Antonio Cuadrado; Rafael León
Journal:  Handb Exp Pharmacol       Date:  2021

9.  Cross-talk between the catalytic core and the regulatory domain in cystathionine β-synthase: study by differential covalent labeling and computational modeling.

Authors:  Ales Hnízda; Vojtech Spiwok; Vojtech Jurga; Viktor Kozich; Milan Kodícek; Jan P Kraus
Journal:  Biochemistry       Date:  2010-11-17       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.